Skip to main content
. 2017 Aug 3;8:371. doi: 10.3389/fneur.2017.00371

Table 3.

Long-term outcomes 1 year after ictus.

Clinical outcomes Urokinase-type plasminogen activator (45) Tissue-type plasminogen activator (41) p-Value
Case fatality, n (%) 6 (13.3) 5 (12.2) 0.875
GOS 4.1 ± 0.7 3.7 ± 0.9 0.178
BI 80.6 ± 17.8 76.3 ± 14.1 0.434
mRS 2.1 ± 1.0 2.3 ± 1.2 0.491

GOS, Glasgow Outcome Scale; BI, Barthel index; mRS, modified Rankin Scale.